Stay updated on Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.

Latest updates to the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check14 days agoChange DetectedAdded related topic links for Multiple Myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page no longer includes the primary disease term 'Multiple myeloma' and removes the 'related topics' and 'MedlinePlus Genetics' sections. This reduces the explicit disease context and access to related resources for the study.SummaryDifference0.2%

- Check29 days agoChange DetectedRevision updated to v3.5.0 and related topics such as MedlinePlus Genetics have been added, and 'Multiple myeloma' is listed as a topic.SummaryDifference0.2%

- Check36 days agoChange DetectedRemoved the related topics entries for Multiple myeloma and MedlinePlus Genetics from the study page. Core study information and eligibility criteria remain unchanged.SummaryDifference0.2%

- Check43 days agoChange DetectedRevision metadata updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo with Pembrolizumab in rrMM Clinical Trial page.